Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching
Reproductive Medicine and Biology · 2026-01 · 25 (1)
DOI: 10.1002/rmb2.70060 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 13.05.2026. Verfasst von Noritoshi Enatsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hanabusa Women's Clinic Kobe city Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To compare clinical outcomes of ART cycles stimulated with follitropin delta, follitropin alpha, or human menopausal gonadotropin (hMG) using a single‐center retrospective cohort with propensity score matching (PSM).
Methods
We analyzed 20 809 ART cycles (2021–2024). PSM adjusted for age, body weight, anti‐Müllerian hormone, antral follicle count, prior ART attempts, stimulation protocol, and trigger method. The matched cohort comprised 7,647 cycles (2549/group). The primary outcome was oocyte yield. Secondary outcomes included blastocyst development, ovarian enlargement ≥ 5 cm, and clinical pregnancy rates.
Results
The primary outcome regarding oocyte yield was statistically indeterminate across different analytical approaches, and the observed differences were clinically marginal. Both recombinant FSH preparations showed higher blastocyst yields and a lower observed incidence of ovarian enlargement ≥ 5 cm compared with hMG; the latter finding, however, does not establish a clinical safety advantage because clinically diagnosed OHSS was not evaluated. Clinical pregnancy rates were comparable among the three groups.
Conclusions
Differences in oocyte yield among follitropin delta, follitropin alpha, and hMG were small and statistically inconsistent. Secondary findings should be interpreted as exploratory, suggesting broadly comparable clinical performance among the three gonadotropin preparations.
Autor:innen und Institutionen
- Hanabusa Women's Clinic Kobe city Japan.
ORCID-Profile: Noritoshi Enatsu, Hiroaki Shibahara
Zitieren
APA
Enatsu, N., Enatsu, K., Enatsu, Y., Yamada, A., Yamada, K., Hayashi, N., Okamoto, E., Kokeguchi, S., Shibahara, H., & Shiotani, M. (2026). Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70060
Vancouver
Enatsu N, Enatsu K, Enatsu Y, Yamada A, Yamada K, Hayashi N, et al. Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70060
BibTeX
@article{Enatsu2026,
author = {Enatsu, Noritoshi and Enatsu, Kunihiro and Enatsu, Yihsien and Yamada, Ai and Yamada, Koji and Hayashi, Nao and Okamoto, Eri and Kokeguchi, Shoji and Shibahara, Hiroaki and Shiotani, Masahide},
title = {Comparative Effectiveness of Follitropin Delta, Follitropin Alpha, and hMG in ART Cycles: A Single‐Center Retrospective Cohort Study With Propensity Score Matching},
journal = {Reproductive Medicine and Biology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1002/rmb2.70060}
}
EUVIMED